Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Liabilities (2020 - 2025)

Agilon Health's Total Liabilities history spans 6 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 9.38% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 9.38%, while the annual FY2025 figure was $1.1 billion, 9.38% down from the prior year.
  • Total Liabilities reached $1.1 billion in Q4 2025 per AGL's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.6 billion in Q1 2024 to a low of $494.7 million in Q4 2021.
  • Average Total Liabilities over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Total Liabilities: skyrocketed 127.37% in 2021, then fell 14.93% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $494.7 million in 2021, then surged by 32.79% to $656.9 million in 2022, then skyrocketed by 64.4% to $1.1 billion in 2023, then grew by 16.96% to $1.3 billion in 2024, then decreased by 9.38% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Total Liabilities are $1.1 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).